Literature DB >> 2714113

Model system evaluating fluorescein-labeled microbeads as internal standards to calibrate fluorescence intensity on flow cytometers.

R F Vogt1, G D Cross, L O Henderson, D L Phillips.   

Abstract

Fluorescence intensity calibration was evaluated in a model system for flow cytometers using commercially available fluorescein-labeled microbeads as internal standards and stabilized fluoresceinated thymus cell nuclei (Fluorotrol) as surrogates for stained mononuclear cells. Spectrophotometrically determined calibration values for the microbeads were used to generate a standard curve that converted green fluorescence histogram channels into molecular equivalents of soluble fluorescein (MESF). In 19 analyses repeated during a single run, the coefficients of variation (CVs) for the derived MESF values on both dimly and brightly stained Fluorotrol populations were less than 2%. In 26 separate determinations over 14 weeks, the CVs of the derived MESF values were less than 3%. The MESF values of the dim and bright Fluorotrol populations derived from the microbead standard curves were both about 50% lower than those determined by direct spectrophotometric analysis of Fluorotrol. The analytical imprecision of fluorescence intensity measurements in this idealized model system has a CV less than 3%, and the analytical inaccuracy shows that calibration in MESF units remains uncertain over about a two-fold range.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714113     DOI: 10.1002/cyto.990100308

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  11 in total

1.  The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group.

Authors:  F Pandolfi; C Alario; E Girardi; L Rava; G Ippolito; A Kunkl; F Aiuti
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

2.  What you need to know when you go with the flow: pitfalls in the use of flow cytometry.

Authors:  M Pallis; R A Robins
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

Review 3.  Flow cytometry. Principles and applications in exercise immunology.

Authors:  H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-11       Impact factor: 11.136

4.  Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis.

Authors:  J Neumüller; M Fischer; R Eberl
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

5.  Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.

Authors:  Y J Geng; G K Hansson
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

6.  Tunable leuko-polymersomes that adhere specifically to inflammatory markers.

Authors:  Gregory P Robbins; Randi L Saunders; Jered B Haun; Jeff Rawson; Michael J Therien; Daniel A Hammer
Journal:  Langmuir       Date:  2010-09-07       Impact factor: 3.882

7.  Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria.

Authors:  J Duchow; A Marchant; A Crusiaux; C Husson; C Alonso-Vega; D De Groote; P Neve; M Goldman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Direct cell surface modification with DNA for the capture of primary cells and the investigation of myotube formation on defined patterns.

Authors:  Sonny C Hsiao; Betty J Shum; Hiroaki Onoe; Erik S Douglas; Zev J Gartner; Richard A Mathies; Carolyn R Bertozzi; Matthew B Francis
Journal:  Langmuir       Date:  2009-06-16       Impact factor: 3.882

Review 9.  Use of laboratory tests for immune biomarkers in environmental health studies concerned with exposure to indoor air pollutants.

Authors:  R F Vogt
Journal:  Environ Health Perspect       Date:  1991-11       Impact factor: 9.031

10.  SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivo.

Authors:  Y Berthois; B Bourrié; S Galiègue; H Vidal; P Carayon; P M Martin; P Casellas
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.